PL1701733T3 - Zabezpieczanie powierzchni narażonych tkanek biologicznych - Google Patents

Zabezpieczanie powierzchni narażonych tkanek biologicznych

Info

Publication number
PL1701733T3
PL1701733T3 PL04809189T PL04809189T PL1701733T3 PL 1701733 T3 PL1701733 T3 PL 1701733T3 PL 04809189 T PL04809189 T PL 04809189T PL 04809189 T PL04809189 T PL 04809189T PL 1701733 T3 PL1701733 T3 PL 1701733T3
Authority
PL
Poland
Prior art keywords
surface protection
biological tissues
exposed biological
relates
exposed
Prior art date
Application number
PL04809189T
Other languages
English (en)
Inventor
Stig Bengmark
Kare Larsson
Björn Lindman
Roland Andersson
Original Assignee
Bioactive Polymers Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0303588A external-priority patent/SE0303588D0/xx
Application filed by Bioactive Polymers Ab filed Critical Bioactive Polymers Ab
Publication of PL1701733T3 publication Critical patent/PL1701733T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/041—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL04809189T 2003-12-30 2004-12-23 Zabezpieczanie powierzchni narażonych tkanek biologicznych PL1701733T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE0303588A SE0303588D0 (sv) 2003-12-30 2003-12-30 Surface protection of exposed biological tissues
US60613004P 2004-09-01 2004-09-01
EP04809189A EP1701733B1 (en) 2003-12-30 2004-12-23 Surface protection of exposed biological tissues
PCT/SE2004/002016 WO2005063278A1 (en) 2003-12-30 2004-12-23 Surface protection of exposed biological tissues

Publications (1)

Publication Number Publication Date
PL1701733T3 true PL1701733T3 (pl) 2008-11-28

Family

ID=39273394

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04809189T PL1701733T3 (pl) 2003-12-30 2004-12-23 Zabezpieczanie powierzchni narażonych tkanek biologicznych

Country Status (10)

Country Link
US (2) US20080019955A1 (pl)
EP (1) EP1701733B1 (pl)
JP (1) JP5015604B2 (pl)
CN (1) CN1917896B (pl)
AT (1) ATE390930T1 (pl)
CA (1) CA2550872C (pl)
DE (1) DE602004012894T2 (pl)
ES (1) ES2305897T3 (pl)
PL (1) PL1701733T3 (pl)
WO (1) WO2005063278A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2380605A1 (en) * 2010-04-19 2011-10-26 InnoRa Gmbh Improved formulations for drug-coated medical devices
WO2013142374A1 (en) * 2012-03-23 2013-09-26 Amirobe, Inc. Compositions and uses of antimicrobial materials with tissue-compatible properties
CN106039393A (zh) * 2016-06-16 2016-10-26 湖州科达化工燃料有限公司 一种抗感染的皮肤用粘合剂
EP3606543A4 (en) 2017-04-06 2020-12-16 Amicrobe, Inc. COMPOSITIONS AND USES OF LOCALLY APPLIED ANTIMICROBIALS WITH IMPROVED PERFORMANCE AND SAFETY
US12383700B2 (en) 2019-06-13 2025-08-12 Hollister Incorporated Reusable urinary catheter products
EP4628107A3 (en) 2019-06-25 2025-12-17 Hollister Incorporated Reusable urinary catheter products
CN118161668B (zh) * 2024-05-11 2024-08-06 健诺维(成都)生物科技有限公司 一种温度敏感性羊膜凝胶材料及制备方法及应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3664939A (en) * 1970-04-22 1972-05-23 Univ California ISOELECTRIC FOCUSING AND FRACTIONATION AMPHOLYTES IN THERMALLY ENGENDERED pH GRADIENTS
SE361829B (pl) * 1972-05-16 1973-11-19 Lkb Produkter Ab
US3901780A (en) * 1974-07-10 1975-08-26 Hoffmann La Roche Isoelectric focusing techniques and devices
US4204929A (en) * 1978-04-18 1980-05-27 University Patents, Inc. Isoelectric focusing method
US4378224A (en) * 1980-09-19 1983-03-29 Nimni Marcel E Coating for bioprosthetic device and method of making same
US5409904A (en) * 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
US5352664A (en) * 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
US5013714A (en) * 1988-12-15 1991-05-07 Lindstrom Richard L Viscoelastic solution
SE8900586L (sv) 1989-02-21 1990-08-22 Pharmacia Ab Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader
US4994277A (en) * 1989-10-31 1991-02-19 Pfizer Hospital Products Group, Inc. Use of xanthan gum for preventing adhesions
US5246707A (en) * 1990-04-26 1993-09-21 Haynes Duncan H Sustained release delivery of water-soluble bio-molecules and drugs using phospholipid-coated microcrystals, microdroplets and high-concentration liposomes
US6235313B1 (en) * 1992-04-24 2001-05-22 Brown University Research Foundation Bioadhesive microspheres and their use as drug delivery and imaging systems
US5851994A (en) * 1994-04-28 1998-12-22 La Jolla Cancer Research Foundation Compositions that inhibit wound contraction and methods of using same
US6294202B1 (en) 1994-10-06 2001-09-25 Genzyme Corporation Compositions containing polyanionic polysaccharides and hydrophobic bioabsorbable polymers
NZ316944A (en) 1995-08-29 1999-08-30 Fidia Advanced Biopolymers Srl Composite biomaterial for preventing surgical adhesions of tissue containing hyaluronic acid derivative
PT1704878E (pt) * 1995-12-18 2013-07-17 Angiodevice Internat Gmbh Composições de polímeros reticulados e métodos para a sua utilização
ES2353840T3 (es) * 1997-04-21 2011-03-07 California Institute Of Technology Recubrimientos tisulares poliméricos multifuncionales.
SE9702698D0 (sv) 1997-07-14 1997-07-14 Stig Bengmark Compositions for lubricating and separating tissues and biological membranes
JP4241985B2 (ja) * 1998-04-24 2009-03-18 株式会社クラレ 医療用接着材
JP4267106B2 (ja) * 1998-10-15 2009-05-27 株式会社クラレ 癒着防止用材料
JP4159682B2 (ja) * 1998-12-22 2008-10-01 株式会社クラレ 止血材
EP1240182A2 (en) * 1999-12-15 2002-09-18 Cubist Pharmaceuticals, Inc. Daptomycin analogs and their use as antibacterial agents
JP2002136588A (ja) * 2000-11-01 2002-05-14 Kuraray Co Ltd 医療用栓材
US7101947B2 (en) * 2002-06-14 2006-09-05 Florida State University Research Foundation, Inc. Polyelectrolyte complex films for analytical and membrane separation of chiral compounds
US7671011B2 (en) * 2003-06-19 2010-03-02 Yeda Research & Development Co. Ltd. Antimicrobial and anticancer lipopeptides

Also Published As

Publication number Publication date
JP2007517027A (ja) 2007-06-28
ATE390930T1 (de) 2008-04-15
US8461104B2 (en) 2013-06-11
CA2550872A1 (en) 2005-07-14
CA2550872C (en) 2016-05-03
EP1701733B1 (en) 2008-04-02
CN1917896B (zh) 2011-07-20
WO2005063278A1 (en) 2005-07-14
JP5015604B2 (ja) 2012-08-29
DE602004012894D1 (de) 2008-05-15
ES2305897T3 (es) 2008-11-01
CN1917896A (zh) 2007-02-21
EP1701733A1 (en) 2006-09-20
US20080019955A1 (en) 2008-01-24
US20100260822A1 (en) 2010-10-14
DE602004012894T2 (de) 2009-05-14

Similar Documents

Publication Publication Date Title
TW200605870A (en) Topical methadone compositions and methods for using the same
TR200100054T2 (tr) Paroksetin metansülfonat
GT199700074A (es) Derivados de 2-(2-oxo-etiliden)-imidazolidin-4-ona
DE69905170T2 (de) Thiazolopyrimidinderivate
GB0015682D0 (en) Sprayable wound care composition
DE502004002571D1 (de) Substituierte 3-pyrrolidin-indol-derivate
WO2000028947A3 (fr) Utilisation d'une substance se liant au recepteur peripherique des benzodiazepines dans le traitement des stress cutanes
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
IL165392A (en) Use of vegfr modulator materials to prepare and protect liver growth drugs, products and kits that include them
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
DE60312211D1 (de) Haarbehandlungsmittel
YU13301A (sh) Muskarinski agonisti i antagonisti
MXPA02002117A (es) Uso de productos leguminosos para el tratamiento de agresiones externas.
TW200509863A (en) Irradiation device for medical use
PL1701733T3 (pl) Zabezpieczanie powierzchni narażonych tkanek biologicznych
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
MXPA03010683A (es) Composicion que contiene un peptido y un pigmento y el uso del mismo para oscurecer la piel.
ZA200210316B (en) Composition and its therapeutic use.
AU2003219046A1 (en) Cationic polymers and the use thereof in cosmetic formulations
TW200731965A (en) Topical pain relief compositions of N,2,3-trimethyl-2-isopropylbutamide and methods for using the same
TR200002847T2 (tr) Biçim VI 5, 6-dikloro-2-(izopropilamino) -1-(beta-L-ribofüranosil) -1H-benzimidazol.
EP1303520A4 (en) THERAPEUTIC COMPOUNDS AND METHODS
BR0009194A (pt) Composição do resorcinol
AU2003219351A1 (en) Topical composition in the form of a gel for treating skin burns
WO2002066492A3 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques.